Advertisement
Screener

Nuvation Bio Inc. (NUVB) Payments to Acquire Held-to-maturity Securities

2.0 / 5 stars · 17/42 Roast Me

Nuvation Bio Inc. Payments to Acquire Held-to-maturity Securities

Nuvation Bio Inc. (NUVB) reported Payments to Acquire Held-to-maturity Securities of $0 for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireHeldToMaturitySecurities · last filed 2021-08-12

  • Nuvation Bio Inc. payments to acquire held-to-maturity securities for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
  • Nuvation Bio Inc. payments to acquire held-to-maturity securities for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
  • Nuvation Bio Inc. payments to acquire held-to-maturity securities for the quarter ending 2020-06-30 was $13.00K.
  • Nuvation Bio Inc. payments to acquire held-to-maturity securities for the quarter ending 2020-03-31 was $21.00K.
Period endPayments to Acquire Held-to-maturity Securities 3 monthPayments to Acquire Held-to-maturity Securities 6 month
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$0.00
10-Q · filed 2021-08-12
2021-03-31$0.00
10-Q · filed 2021-05-17
2020-06-30$13.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$34.00K
10-Q · filed 2021-08-12
2020-03-31$21.00K
10-Q · filed 2021-05-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Biohaven Ltd. (BHVN)United States$1.990B-3.83
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Generate Biomedicines, Inc. (GENB)United States$2.052B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B